News
19h
GlobalData on MSNPrasad’s FDA exit may accelerate cell and gene therapy approvalsVinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...
Q2 2025 Earnings Call Transcript July 30, 2025 Entergy Corporation beats earnings expectations. Reported EPS is $1.05, expectations were $0.91. Operator: Good morning. My name is Greg, and I will be ...
The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...
Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results